National Peroxide Ltd Reports Strong Quarterly Turnaround Amid Challenging Market

Quarterly Financial Performance Surges

National Peroxide Ltd’s latest quarterly results reveal a significant improvement across key financial metrics. The company recorded a Profit Before Depreciation, Interest and Tax (PBDIT) of ₹6.99 crores, marking the highest quarterly figure in its recent history. This robust operating profit translated into an operating profit to net sales ratio of 10.12%, also the highest recorded for the company in the quarter ended December 2025.

Profit Before Tax (PBT) excluding other income stood at ₹1.46 crores, while the Profit After Tax (PAT) reached ₹2.41 crores, both representing peak quarterly performances. Earnings Per Share (EPS) surged to ₹3.18, underscoring the company’s improved profitability on a per-share basis.

This marked improvement is reflected in the company’s financial trend score, which has shifted from a negative -2 three months ago to a positive 18, signalling a clear reversal in momentum and operational efficiency.

Stock Price and Market Capitalisation Context

National Peroxide’s stock price has responded positively to the improved financials, closing at ₹425.00 on 6 February 2026, up 3.82% from the previous close of ₹409.35. The stock traded within a range of ₹407.00 to ₹436.00 during the day, reflecting increased investor interest. Despite this uptick, the current price remains well below its 52-week high of ₹770.00, indicating room for recovery if the positive trend sustains.

The company’s market capitalisation grade remains modest at 4, consistent with its micro-cap status within the commodity chemicals sector. However, the recent upgrade in its Mojo Grade from Sell to Strong Sell on 7 May 2025, with a Mojo Score of 17.0, suggests that while the company is showing operational improvements, market sentiment remains cautious.

Comparative Performance Against Sensex

Examining National Peroxide’s stock returns relative to the benchmark Sensex index reveals a mixed picture. Over the past week, the stock outperformed the Sensex with a 6.17% gain compared to the index’s 0.88%. However, over the one-month period, the stock declined by 1.09%, slightly better than the Sensex’s 2.43% fall.

Year-to-date, National Peroxide has underperformed, dropping 9.19% against the Sensex’s 2.61% decline. The one-year performance is notably weak, with the stock plunging 40.56%, while the Sensex gained 6.32%. This underperformance over the longer term highlights the challenges the company has faced, despite the recent quarterly improvement.

Longer-term returns for three, five, and ten years are not available for National Peroxide, but the Sensex’s robust gains of 37.17%, 63.60%, and 237.15% respectively over these periods underscore the company’s lagging relative performance within the broader market.

Sector and Industry Dynamics

Operating within the commodity chemicals sector, National Peroxide faces cyclical demand pressures and raw material cost volatility. The recent margin expansion to 10.12% operating profit to net sales ratio is a positive sign of improved cost management and pricing power in a competitive environment.

However, the company’s modest market capitalisation and micro-cap status limit its ability to leverage economies of scale compared to larger peers. Investors should weigh the company’s improving operational metrics against sector headwinds and the broader macroeconomic environment.

Outlook and Investor Considerations

National Peroxide’s recent quarterly results mark a significant improvement in financial health, with the highest quarterly PBDIT, PBT, PAT, and EPS recorded in recent history. The positive shift in the financial trend score from negative to positive is encouraging and suggests that operational initiatives may be bearing fruit.

Nevertheless, the stock’s long-term underperformance relative to the Sensex and the company’s current Strong Sell Mojo Grade indicate that caution remains warranted. Investors should monitor whether the company can sustain margin expansion and revenue growth in upcoming quarters, especially given the volatility in commodity chemical markets.

With the stock price still well below its 52-week high, there is potential upside if the company continues to deliver on its improving fundamentals. However, the micro-cap nature and sector-specific risks mean that risk management and diversification remain key for investors considering exposure to National Peroxide.

Valuation and Market Sentiment

At a current price of ₹425.00, National Peroxide trades at a discount to its recent highs, reflecting tempered market sentiment. The company’s market cap grade of 4 and Mojo Score of 17.0, despite the recent upgrade, suggest that the market remains cautious about the sustainability of the turnaround.

Investors should consider the company’s improving operating metrics alongside broader market trends and sector outlooks before making investment decisions. The commodity chemicals sector’s cyclical nature means that earnings can be volatile, and National Peroxide’s recent positive financial trend will need to be confirmed over multiple quarters to regain investor confidence fully.

Conclusion

National Peroxide Ltd’s December 2025 quarter results represent a meaningful step forward in reversing a previously flat financial trend. The company’s highest-ever quarterly profitability and margin expansion provide a foundation for cautious optimism. However, the stock’s historical underperformance and current market sentiment warrant a measured approach from investors.

Continued monitoring of quarterly results and sector dynamics will be essential to assess whether National Peroxide can sustain this positive momentum and translate it into long-term shareholder value.

Unlock special upgrade rates for a limited period. Start Saving Now →